Conceptio
›
multiple-myeloma
Topic
multiple-myeloma
Knowledge-graph topic
· documents ABOUT multiple-myeloma across the archive
675
Documents about multiple-myeloma
Documents about multiple-myeloma
Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma
#859498
ClinicalTrials.gov
Treatment With a Scheme With Low Doses of Bortezomib / Melphalan / Prednisone (MPV) in Patients With Multiple Myeloma
#861039
ClinicalTrials.gov
Exercise in Patients With Multiple Myeloma
#862102
ClinicalTrials.gov
A Study of MBS314 in Participants With Relapsed/Refractory Multiple Myeloma.
#874917
ClinicalTrials.gov
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
#878984
ClinicalTrials.gov
A Real-World Observational Study: Zevorcabtagene Autoleucel Injection in Patients with Relapsed/Refractory Multiple Myeloma
#879692
ClinicalTrials.gov
Evaluation of Clinical Treatment of Multiple Myeloma Based on Multi-omics
#881345
ClinicalTrials.gov
Sorafenib and Bortezomib Treatment for Relapsed or Refractory Multiple Myeloma Patients
#882420
ClinicalTrials.gov
LCI-HEM-MYE-CRD-002: Carfilzomib-Revlimid-Dexamethasone-Elotuzumab in Relapsed/Refractory Multiple Myeloma
#892223
ClinicalTrials.gov
Selinexor, Carfilzomib, and Dexamethasone Versus Placebo, Carfilzomib, and Dexamethasone in Multiple Myeloma
#892243
ClinicalTrials.gov
Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies
#892899
ClinicalTrials.gov
A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma
#903627
ClinicalTrials.gov
Study of PD-1Ab21-BCMA CAR-T Therapy for Consolidation of Multiple Myelomawith Renal Dysfunction
#837598
ClinicalTrials.gov
Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial
#296808
Gestión del Repositorio Documental de la Universidad de Salamanca
Study of the Safety and Effectiveness of LGH447 and BYL719 in Patients With Relapsed and Refractory Multiple Myeloma
#851980
ClinicalTrials.gov
ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Ultra-High-Risk Multiple Myeloma
#899802
ClinicalTrials.gov
UARK 2009-09 Myeloma Cure Project: Prospective Trial of Indefinite Revlimid Maintenance Versus Observation for Currently Event-Free Patients With Multiple Myeloma
#905217
ClinicalTrials.gov
Ixazomib Plus Lenalidomide Plus Dexamethasone for Newly Diagnosed Myeloma Patients
#806089
ClinicalTrials.gov
NMP in Relapsed / Refractory Myeloma
#860352
ClinicalTrials.gov
Hematopoietic Stem Cell Transplantation in Myeloma
#894430
ClinicalTrials.gov
MRD-Adaptive Guided Immunotherapy With CAR-T for Transplant-Ineligible Patients With Multiple Myeloma
#28326
ClinicalTrials.gov
Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma
#201774
ClinicalTrials.gov
Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma
#448320
ClinicalTrials.gov
Study Evaluating the Safety and Efficacy of JCARH125 in Subjects With Relapsed and/or Refractory Multiple Myeloma
#454036
ClinicalTrials.gov
Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma
#800493
ClinicalTrials.gov
Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma
#806520
ClinicalTrials.gov
Combination of Revlimid, Melphalan and Dexamethasone as First Line Treatment for Multiple Myeloma
#807612
ClinicalTrials.gov
Intravenous rhMBL in Patients With Multiple Myeloma Receiving Chemotherapy Followed by Stem Cell Transplant
#810829
ClinicalTrials.gov
A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma
#831292
ClinicalTrials.gov
A Trial for Relapsed and Relapsed/Refractory Multiple Myeloma Patients
#834020
ClinicalTrials.gov
A Study in Relapsed and/or Refractory Multiple Myeloma Patients Treated With Ixazomib Plus Lenalidomide and Dexamethasone
#837209
ClinicalTrials.gov
Lenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple Myeloma
#839902
ClinicalTrials.gov
A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma
#859056
ClinicalTrials.gov
A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma
#882895
ClinicalTrials.gov
Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma
#884863
ClinicalTrials.gov
Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma
#905944
ClinicalTrials.gov
A Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma
#908800
ClinicalTrials.gov
Targeting CD19 and BCMA CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Multiple Myeloma
#915975
ClinicalTrials.gov
Efficacy and Safety of Anitocabtagene Autoleucel in Participants With Newly Diagnosed Multiple Myeloma (GEM-AnitoFIRST)
#967469
ClinicalTrials.gov
Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial
#967910
ClinicalTrials.gov
Phase II Study of Simvastatin for Relapsed/Refractory Myeloma
#829312
ClinicalTrials.gov
AZD6244 (Selumetinib) in Treating Patients With Multiple Myeloma
#831138
ClinicalTrials.gov
Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment
#853610
ClinicalTrials.gov
Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma
#832532
ClinicalTrials.gov
Fluoroquinolone Resistance Prevalence Study
#184884
ClinicalTrials.gov
eHealth for the Elderly
#886061
ClinicalTrials.gov
Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma
#154633
ClinicalTrials.gov
Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma
#181581
ClinicalTrials.gov
Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents
#426793
ClinicalTrials.gov
Cardiac Toxicity and Prognostic Value of New Echocardiographic Indicators in the Treatment of Primary Multiple Myeloma
#807279
ClinicalTrials.gov
← Previous
Page 7 of 20
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.